Advanced Gastroenteropancreatic Neuroendocrine Tumor Clinical Trials in Tianjin, Tianjin Municipality

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.